Sicart Associates LLC Ptc Therapeutics, Inc. Transaction History

Sicart Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$40.4 - $59.1 $124,230 - $181,732	-3,075 Reduced 37.61%	5,100 $207,000
Q1 2021 May 10, 2021	SELL	$46.8 - $68.92 $1,170 - $1,723	-25 Reduced 0.3%	8,175 $387,000
Q1 2020 Apr 22, 2020	SELL	$32.37 - $59.36 $16,994 - $31,164	-525 Reduced 6.02%	8,200 $366,000
Q3 2019 Oct 21, 2019	BUY	$33.82 - $48.17 $18,601 - $26,493	550 Added 6.73%	8,725 $295,000
Q1 2018 Apr 12, 2018	BUY	$17.46 - $32.59 $142,735 - $266,423	8,175 New	8,175 $221,000

232

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.54B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Sicart Associates LLC with notifications on news.